Isolation and Purification of Antibodies Using Protein A Affinity Chromatography
AssigneeAbbVie Inc.
InventorsRobert K. Hickman, Qing Huang, Cheryl L. Weed, Scott T. Ennis, Barbara Perilli-Palmer, Min Wan
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbVie Inc.
InventorsRobert K. Hickman, Qing Huang, Cheryl L. Weed, Scott T. Ennis, Barbara Perilli-Palmer, Min Wan
Estimating the term…
Disclosed herein are methods for the isolation and purification of antibodies wherein the use of an affinity chromatographic step results in an antibody composition sufficiently pure for pharmaceutical uses. The methods described herein comprise pH viral reduction/inactivation, ultrafiltration/diafiltration, affinity chromatography, preferably Protein A affinity, ion exchange chromatography, and hydrophobic chromatography. Further, the present invention is directed toward pharmaceutical compositions comprising one or more antibodies of the present invention.
A method for producing a host cell-protein (HCP) reduced antibody preparation from a sample mixture comprising an antibody and at least one HCP, said method comprising:
The method of claim 11, wherein said anion exchange resin is Q-sepharose.
The pharmaceutical composition of claim 27, wherein said antibody is either an anti-IL-12 antibody or antigen-binding portion thereof, or an anti-TNFα antibody or antigen-binding portion thereof.
The pharmaceutical composition of claim 27, wherein said composition is substantially free of HCPs.
Dependencies are inferred from the claim text.